President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

the maker of Ozempic and Wegovy, the popular weight-loss drugs. The company is so important to the Danish economy — it has recently accounted for half of Denmark’s private sector job growth ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type 2 diabetes and chronic kidney disease, Novo Nordisk said.

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

Trump threatened "very high" tariffs on Denmark amid Greenland dispute, raising fears of higher prices for Danish pharmaceuticals.

Similarly, The Hill's Joseph Choi reports that a tariff against Denmark could make two widely used drugs, Ozempic and Wegovy, even more expensive in the United States. "Danish multinational ...

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland could disrupt one export that is wildly popular in America: Ozempic.

Ozempic and Wegovy are doing more than just helping people to lose weight. The novel drugs are also boosting pharma stocks — and Denmark's economy. The country's GDP expanded by 2% over the ...

Ozempic is so popular that Novo Nordisk’s market value has skyrocketed to almost $300 billion. If Trump imposes steep tariffs on Denmark, it could at least temporarily increase the consumer ...